MNCs Applaud Shanghai Zhangjiang Hi-tech Park Pilot Program To Accelerate Biomaterial Imports
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Ten research centers in Shanghai Zhangjiang Hi-tech Park have passed inspections by the General Administration of Quality Supervision, Inspection and Quarantine for the first round of a pilot program aimed at simplifying import procedures and at shortening the time it takes to approve imported biomaterial